During the past decade, Paracelsus-Elena Klinik conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paracelsus-Elena Klinik" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Mundipharma Research GmbH & Co KG" with 2 trials sponsored, "Alkahest, Inc." with 1 trials sponsored, "Allon Therapeutics" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paracelsus-Elena Klinik" #1 collaborator was "Institute for Neurodegenerative Disorders" with 2 trials as a collaborator, "Competence Network on Parkinson's Disease" with 1 trials as a collaborator, "Deutsche Parkinson Vereinigung" with 1 trials as a collaborator, "European MSA-Study Group" with 1 trials as a collaborator and "Federal Institute of Education and Sience" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Paracelsus-Elena Klinik" are "Parkinson's Disease" (8 trials), "Parkinson Disease" (6 trials), "Multiple System Atrophy" (2 trials), "Huntington's Disease" (1 trials) and "Minocycline" (1 trials). Many other conditions were trialed in "Paracelsus-Elena Klinik" in a lesser frequency.

Most popular intervention types in "Paracelsus-Elena Klinik" are "Drug" (20 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "1. Tesofensine (NS 2330)" (1 trials), "ACR325" (1 trials), "AKST4290" (1 trials) and "Apomorphine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paracelsus-Elena Klinik" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Paracelsus-Elena Klinik". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Paracelsus-Elena Klinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Paracelsus-Elena Klinik, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".